Amgen Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $9.13B | $11.97B | $10.94B | $7.63B | $7.99B | $6.27B | $6.04B | $6.95B |
| Accounts Receivable | $9.57B | $6.78B | $7.27B | $5.56B | $4.90B | $4.53B | $4.06B | $3.58B |
| Inventory | $6.23B | $7.00B | $9.52B | $4.93B | $4.09B | $3.89B | $3.58B | $2.94B |
| Total Current Assets | $29.06B | $29.03B | $30.33B | $22.19B | $19.39B | $21.14B | $18.44B | $37.62B |
| Property, Plant & Equipment | $7.91B | $6.54B | $5.94B | $5.43B | $5.18B | $4.89B | $4.93B | $4.96B |
| Goodwill | $18.68B | $18.64B | $18.63B | $15.53B | $14.89B | $14.69B | $14.70B | $14.70B |
| Intangible Assets (Excl. Goodwill) | $22.28B | $27.70B | $32.64B | $16.08B | $15.18B | $16.59B | $19.41B | $7.44B |
| Total Assets | $90.59B | $91.84B | $97.15B | $65.12B | $61.17B | $62.95B | $59.71B | $66.42B |
| Liabilities | ||||||||
| Accounts Payable | $2.37B | $1.91B | $1.59B | $1.57B | $1.37B | $1.42B | $1.37B | $1.21B |
| Total Current Liabilities | $25.49B | $23.10B | $18.39B | $15.69B | $12.18B | $11.65B | $12.84B | $13.49B |
| Long-Term Debt | $50.01B | $56.55B | $63.17B | $37.35B | $33.22B | $32.90B | $26.95B | $29.51B |
| Total Liabilities | $81.93B | $85.96B | $90.92B | $61.46B | $54.47B | $53.54B | $50.03B | $53.92B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-25.11B | $-27.59B | $-26.55B | $-28.62B | $-24.60B | $-21.41B | $-21.33B | $-17.98B |
| Total Stockholders' Equity | $8.66B | $5.88B | $6.23B | $3.66B | $6.70B | $9.41B | $9.67B | $12.50B |